Related Experiment Video
Updated: Feb 6, 2026

Modeling Persistent Pseudomonas aeruginosa Infection in Wounded Zebrafish Larvae
Published on: June 13, 2025
Colistin susceptibility test evaluation of multiple-resistance-level Pseudomonas aeruginosa isolates generated in a
Mumina Javed1,2, Viola Ueltzhoeffer1, Maximilian Heinrich1,2
1Interfaculty Institute of Microbiology and Infection Medicine Tübingen, Institute of Medical Microbiology and Hygiene, Tübingen, Germany.
Objectives:
Colistin is a last-resort antibiotic against the critical-status pathogen Pseudomonas aeruginosa. There is still uncertainty regarding how to accurately measure colistin susceptibility in P. aeruginosa. Evaluation of antimicrobial susceptibility testing (AST) methods is largely hampered by the lack of resistant isolates and those around the susceptibility breakpoint. The aim of this study was to generate such strains in a morbidostat device for use in AST method evaluation.
Methods:
A morbidostat device was used to cultivate susceptible clinical strains into isolates with a wide range of colistin MICs. Subsequently, five commercial AST methods were compared against the gold standard broth microdilution (BMD) method: MICRONAUT-S, SensiTest, Sensititre, Rapid Polymyxin Pseudomonas and Etest.
Results:
A total of 131 P. aeruginosa isolates were used for colistin susceptibility test evaluation (100 colistin susceptible and 31 colistin resistant). The 31 colistin-resistant isolates evolved resistance in the morbidostat to different MIC ranges (4-512 mg/L, 100% resistance generation efficacy). The categorical agreement (CA) rates for MICRONAUT-S, SensiTest and Rapid Polymyxin Pseudomonas were 94.7%, 93.9% and 92.4%, respectively. The Sensititre achieved the highest CA score (96.9%), whereas the Etests had the lowest CA score (84%). The very major discrepancy (VMD) rates for all tests were between 3.2% and 67.7%.
Conclusions:
The morbidostat device can efficiently provide laboratories with colistin-resistant strains for test evaluation. Although CA rates were high for commercial AST methods except for Etests, none met the ≤1.5% CLSI limit for VMD rates. Performance was generally inferior when using isolates with low-level resistance.
Insights
Generating colistin-resistant Pseudomonas aeruginosa strains in a morbidostat is effective for evaluating antimicrobial susceptibility testing (AST) methods. However, commercial AST methods showed high discrepancy rates, especially for low-level resistance, failing to meet clinical guidelines.
Area of Science:
- Microbiology
- Clinical Science
- Infectious Diseases
Background:
- Colistin is a critical last-resort antibiotic for treating Pseudomonas aeruginosa infections.
- Accurate susceptibility testing for colistin in P. aeruginosa is challenging due to a lack of well-characterized resistant isolates.
- Evaluating antimicrobial susceptibility testing (AST) methods requires a diverse panel of resistant strains, including those near the susceptibility breakpoint.
Purpose of the Study:
- To generate colistin-resistant Pseudomonas aeruginosa strains using a morbidostat device for AST method evaluation.
- To compare the performance of five commercial AST methods against the gold standard broth microdilution (BMD) method for colistin susceptibility testing.
Main Methods:
- A morbidostat device was employed to cultivate susceptible P. aeruginosa strains, inducing a range of colistin minimum inhibitory concentrations (MICs).
- Five commercial AST methods (MICRONAUT-S, SensiTest, Sensititre, Rapid Polymyxin Pseudomonas, Etest) were evaluated.
- Broth microdilution (BMD) served as the gold standard for comparison.
Main Results:
- A total of 131 P. aeruginosa isolates were tested (100 susceptible, 31 resistant).
- The morbidostat successfully generated 31 resistant isolates with MICs ranging from 4-512 mg/L, demonstrating 100% resistance generation efficacy.
- Sensititre achieved the highest categorical agreement (CA) at 96.9%, while Etest had the lowest at 84%. Very major discrepancy (VMD) rates exceeded the CLSI limit for all tested methods.
Conclusions:
- The morbidostat is an efficient tool for generating colistin-resistant P. aeruginosa strains crucial for AST method validation.
- While commercial AST methods showed high CA rates (except Etest), none met the stringent CLSI VMD rate limit of ≤1.5%.
- The performance of AST methods was notably inferior when assessing isolates with low-level colistin resistance.
Related Concept Videos
Magnetic Susceptibility and Permeability
When diamagnetic materials are placed under an external magnetic field, the moments opposite to the field are induced. Hence, the susceptibility for diamagnets has a minimal negative value of 10-5–10-6. Since...
Multiple Allele Traits
Leveling Effect
Resistivity
Resistance
Susceptibility, Permittivity and Dielectric Constant

